Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Drug Failure Deals AstraZeneca Fresh Blow (Reuters) Reuters - AstraZeneca Plc suffered its third\setback in two months on Friday as lung cancer drug Iressa\failed to help patients live longer in a major clinical trial,\sending its shares down as much as 9.2 percent.
